MyCLL for healthcare professionals

MyCLL is a personalised, self-management programme to support adult patients prescribed Calquence®▼ (acalabrutinib) for chronic lymphocytic leukaemia (CLL). (Find the prescribing information for acalabrutinib here).

MyCLL supports patients through online and printed tools to address disease awareness and CLL management concerns, while additional tools – such as text message medication reminders – recognise the challenges of self-management and support treatment adherence.

It is simple for patients to register; you can either sit with them and take them through the short online enrolment or they can register themselves at home.

Find out more by watching the video or download the information leaflet below.